Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Debio 025 (Alisporivir) Combination Therapy in Treatment-Naïve Chronic Hepatitis C Genotype 1
NCT00854802Phase 2Completed
- Sponsor
- Debiopharm
- Start
- Jan 2009
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of alisporivir in hepatitis C (HCV), sponsored by Debiopharm. Started Jan 2009; status: completed.
02
Drugs
alisporivir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00854802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00854802.